Barclays’s Insmed INSM Stock Holding History

Barclays’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Buy	+2,500	New	+$303K	﹤0.01%	3552
2026 Q1	–	Sell	-21,000	Closed	-$3.65M	–	5234
2025 Q4	$3.65M	Hold	21,000	–	–	﹤0.01%	2468
2025 Q3	$3.02M	Buy	+21,000	New	+$2.57M	﹤0.01%	2557
2024 Q3	–	Sell	-68,300	Closed	-$4.58M	–	5373
2024 Q2	$4.58M	Buy	68,300 +13,500	+25%	+$524K	﹤0.01%	1604
2024 Q1	$1.49M	Buy	+54,800	New	+$1.53M	﹤0.01%	2805
2020 Q1	–	Sell	-142,300	Closed	-$3.4M	–	6289
2019 Q4	$3.4M	Buy	+142,300	New	+$2.89M	﹤0.01%	2429
2019 Q2	–	Sell	-300	Closed	-$9K	–	7079
2019 Q1	$9K	Buy	+300	New	+$7.78K	﹤0.01%	6584
2018 Q2	–	Sell	-100	Closed	-$2K	–	7097
2018 Q1	$2K	Buy	+100	New	+$2.63K	﹤0.01%	6900
2017 Q4	–	Sell	-58,700	Closed	-$1.83M	–	6998
2017 Q3	$1.83M	Buy	+58,700	New	+$1.12M	﹤0.01%	2441
2014 Q2	–	Sell	-605,000	Closed	-$11.5M	–	7689
2014 Q1	$11.5M	Buy	+605,000	New	+$11.5M	0.01%	1047

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Barclays's INSM Position: Q2 2026 in Review

Barclays reduced its Insmed (INSM) stake by 33% in Q2 2026, selling an estimated $10.9M and leaving 185,643 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Barclays first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.4M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Barclays held 185,643 shares of Insmed worth $19.8M as of Q2 2026.
Barclays sold 90,088 Insmed shares in Q2 2026, an estimated $10.9M.
Insmed made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1134 holding.
Barclays first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
Barclays's Insmed position peaked at $77.4M in Q4 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.